Preventing Skeletal Related Events In Prostate Cancer

Panelists discuss the prevention of the skeletal-related events associated with androgen deprivation therapy-related bone mineral density loss in patients with prostate cancer.

To view more from this discussion, visit onclive.com/peer-exchange/treating-mcrpc

  • Preventing Skeletal-Related Events in Prostate Cancer ( Download)
  • Identification and Prevention of Skeletal-Related Events ( Download)
  • Reducing Skeletal-Related Events in Prostate Cancer ( Download)
  • Optimizing Bone Health in Patients with Prostate Cancer ( Download)
  • Advances in prevention and treatment of bone metastases in prostate cancer ( Download)
  • Bone Metastases and Mortality ( Download)
  • Bone Health in Prostate Cancer ( Download)
  • CRPC: Preventing Complications With Bone-Targeted Agents ( Download)
  • Management of Bone Metastases and Bone Health in Patients With Prostate Cancer ( Download)
  • Updates on Managing Bone Disease in Multiple Myeloma ( Download)
  • Bone Metastases in CRPC: Prognostic for Survival ( Download)
  • Bone Targeted Agents in Metastatic Prostate Cancer: Denosumab, Bisphosphonates and Radium-223 ( Download)
  • Putting the Brakes on Prostate Cancer Progression in Bone ( Download)
  • Bone Metastases and Mortality: Can We Be Doing More ( Download)
  • Preventing Bone Complications From Bone Metastases ( Download)